Valuation: Nipro Corporation

Market Cap 26TCr 159.22Cr 139.14Cr 128.63Cr 118.84Cr 223.79Cr 15TCr 227.84Cr 1.53TCr 601.83Cr 7.49TCr 598.05Cr 584.84Cr P/E 2027 *
18.3x
P/E 2028 * 14.2x
Enterprise Value 77TCr 474.28Cr 414.47Cr 383.15Cr 353.99Cr 666.62Cr 46TCr 678.7Cr 4.57TCr 1.79TCr 22TCr 1.78TCr 1.74TCr EV / Sales 2027 *
1.1x
EV / Sales 2028 * 1.03x
Free-Float
87.38%
Yield 2027 *
2.1%
Yield 2028 * 2.53%
14/07 Jefferies Adjusts Nipro's Price Target to 1,700 Yen From 1,500 Yen, Keeps at Hold MT
12/05 Nipro Corporation Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2026 and Fiscal Year Ending March 31, 2027 CI
12/05 Nipro Corporation Announces Year-End Dividend for Fiscal Year Ended March 31, 2026, Payable on June 10, 2026; Provides Second Quarter-End and Year-End Dividend Guidance for Fiscal Year Ending March 31, 2027 CI
01/05 Jefferies Adjusts Nipro's Price Target to 1,500 Yen From 1,300 Yen, Keeps at Hold MT
11/03 Nipro Fixes Record Date for Fiscal 2026 Year-End Dividend MT
09/02 Nipro Corporation Reports Earnings Results for the Nine Months Ended December 31, 2025 CI
24/12 Nipro Corporation Announces Establishment of Wholly Owned Subsidiary in Singapore CI
10/11 Nipro Corporation Announces Dividend for the Second Quarter End of Fiscal Year Ending March 31, 2026, Payable on December 10, 2025 CI
10/25/10 Samsung Bioepis Partners With Nipro to Commercialize Biosimilars in Japan MT
09/25/09 Samsung Bioepis Co., Ltd. Enters into A Strategic Partnership with NIPRO Corporation for Commercialization of Multiple Biosimilars in Japan CI
13/25/13 Jefferies Adjusts Nipro's Price Target to 1,300 Yen from 1,400 Yen, Keeps at Hold MT
12/25/12 Nipro Corporation Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2025 and Fiscal Year Ending March 31, 2026 CI
12/25/12 Nipro Corporation Announces Dividend for the Year Ended March 31, 2025, Effective June 27, 2025; Provides Dividend Guidance for the Second Quarter End of Fiscal Year Ending March 31, 2026 CI
1 day+2.79%
Current month+21.02%
Current year+21.02%
3 years 8.23
Extreme 8.23
9.96
5 years 8.23
Extreme 8.23
9.96
10 years 8.23
Extreme 8.23
9.96
Manager TitleAgeSince
President 58 26/06/2025
Chief Administrative Officer 57 26/06/2025
Corporate Officer/Principal - -
Director TitleAgeSince
Chairman 81 26/06/2025
Director/Board Member 53 01/06/2009
Director/Board Member 58 01/06/2009
Change 5-day change 1-year change 3-year change Capi.($)
+2.79%-.--% - - 155.99Cr
-3.42%-7.18%-32.62%-17.58% 16TCr
-5.11%-5.40%-11.62%-9.53% 11TCr
-1.26%-0.72%+1.76%+57.91% 5.96TCr
+0.35%-0.29%+40.73%+55.54% 5.25TCr
-2.07%-3.61%-14.93%-41.92% 4.24TCr
-4.73%-10.11% - - 3.43TCr
-2.92%+0.75%-13.14%-46.02% 2.95TCr
-0.57%+0.44%+59.32%-7.14% 2.54TCr
-3.83%-3.09%-7.56%-8.88% 2.12TCr
Average -2.08%-0.35%+2.74%-2.20% 5.91TCr
Weighted average by Cap. -2.96%-0.94%-7.85%-1.96%

Financials

2027 *2028 *
Net sales 70TCr 431.06Cr 376.7Cr 348.23Cr 321.73Cr 605.87Cr 41TCr 616.84Cr 4.15TCr 1.63TCr 20TCr 1.62TCr 1.58TCr 73TCr 448.31Cr 391.78Cr 362.17Cr 334.6Cr 630.12Cr 43TCr 641.53Cr 4.32TCr 1.69TCr 21TCr 1.68TCr 1.65TCr
Net income 1.45TCr 8.94Cr 7.81Cr 7.22Cr 6.67Cr 13Cr 858.76Cr 13Cr 86Cr 34Cr 420.51Cr 34Cr 33Cr 1.89TCr 12Cr 10Cr 9.43Cr 8.72Cr 16Cr 1.12TCr 17Cr 112.51Cr 44Cr 549.3Cr 44Cr 43Cr
Net Debt 51TCr 315.06Cr 275.33Cr 254.53Cr 235.15Cr 442.83Cr 30TCr 450.86Cr 3.04TCr 1.19TCr 15TCr 1.18TCr 1.16TCr 49TCr 304.25Cr 265.88Cr 245.79Cr 227.08Cr 427.64Cr 29TCr 435.38Cr 2.93TCr 1.15TCr 14TCr 1.14TCr 1.12TCr
Logo Nipro Corporation
Nipro Corp is a Japan-based company mainly engaged in the medical, pharmaceutical, and pharma packaging businesses. It has three segments. The Medical segment consists of the domestic business division and the international business division. The domestic business division sells medical devices related to injections and infusions, artificial organs, high-performance medicines, and dialysis. The international business division, centered on the head office, has medical device manufacturing and sales bases overseas for regional expansion, selling medical devices related to injections and infusions, artificial organs, and diabetes. The Pharmaceutical segment sells pharmaceuticals related to kit preparation containers on a contract basis from pharmaceutical companies. The Pharma Packaging segment sells medical glass products such as glass tubes and ampoules, thermos flasks, and kit preparation containers in Japan.
Employees
38,593
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
1,581.00JPY
Average target price
1,916.00JPY
Spread / Average Target
+21.19%

Quarterly revenue - Rate of surprise